NCT02333344View on ClinicalTrials.gov

The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 30, 2015

Primary Completion Date

January 28, 2020

Study Completion Date

January 28, 2020

Conditions
Prosthetic Fixation After Cementless Total Hip Arthroplasty
Interventions
DRUG

Zoledronic acid 5mg

two-year Zoledronic acid 5mg infusion treatment

Trial Locations (1)

200011

Novartis Investigative Site, Shanghai

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY